Objectives: To determine the safety and effectiveness of manual vacuumaspiration (MVA) in treating first trimester pregnancy loss. Place & duration of study: Departmentof Gynecology, Shahina Jamil Teaching Hospital, Abbottabad, Pakistan, from September2013 to December 2014. Study design: Descriptive cross-sectional study. Materials andmethods: All the patients who were less than 12 weeks of gestation and diagnosed with missedabortion, incomplete abortion, having retained products of conception after normal deliveryand anembryonic pregnancy were included in the study. Diagnosis was made on the basis ofhistory, physical examination and ultrasonography. Urine pregnancy test and β-HCG were donein selected patients. Last menstrual period and USG were used to determine the gestationalage. Manual vacuum aspiration was carried out under Para cervical block using “Ipas EasyGrip” cannula with a 60ml syringe attached to it to create a negative pressure. Completenessof the procedure was determined and products of conception were sent for histopathologicalexamination. Results: There were 165 patients enrolled in this study. All study subjects weremarried. Mean age of the patients was 27.60± 4.86 years. Fifty patients had a previous historyof abortion. Mean parity was 2.98± 2.22 and mean gestational age was 8.23±1.6 weeks.The maximum number of patients, 80%, belonged to age group of 20-30 years. There were37 patients who were presented with first pregnancy. The number of multigravida and grandmultigravida patients were equal, 64 cases in each group. The main reason for undergoingMVA in our study subjects was missed and incomplete abortion followed by retained productsof conception and anembryonic pregnancy. Conclusion: MVA is a preferred mode of treatingfirst trimester pregnancy loss as it is a simple, safe and cost-effective procedure. MVA should beused preferentially in rural areas where there is a limited access to health care facilities, powerout-breaks are common and advanced medical equipment is not available.
Study design: Descriptive cross-sectional study. Materials and methods: All the patients who were less than 12 weeks of gestation and diagnosed with missed abortion, incomplete abortion, having retained products of conception after normal delivery and anembryonic pregnancy were included in the study. Diagnosis was made on the basis of history, physical examination and ultrasonography. Urine pregnancy test and β-HCG were done in selected patients. Last menstrual period and USG were used to determine the gestational age. Manual vacuum aspiration was carried out under Para cervical block using "Ipas Easy Grip" cannula with a 60ml syringe attached to it to create a negative pressure. Completeness of the procedure was determined and products of conception were sent for histopathological examination. Results: There were 165 patients enrolled in this study. All study subjects were married. Mean age of the patients was 27.60± 4.86 years. Fifty patients had a previous history of abortion. Mean parity was 2.98± 2.22 and mean gestational age was 8.23±1.6 weeks. The maximum number of patients, 80%, belonged to age group of 20-30 years. There were 37 patients who were presented with first pregnancy. The number of multigravida and grand multigravida patients were equal, 64 cases in each group. The main reason for undergoing MVA in our study subjects was missed and incomplete abortion followed by retained products of conception and anembryonic pregnancy. Conclusion: MVA is a preferred mode of treating first trimester pregnancy loss as it is a simple, safe and cost-effective procedure. MVA should be used preferentially in rural areas where there is a limited access to health care facilities, power outbreaks are common and advanced medical equipment is not available.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.